Senior Manager/Associate Director, Commercial Analytics at Corcept Therapeutics

Redwood City, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, EndocrinologyIndustries

Requirements

Highly analytical and results-oriented mindset
Ability to analyze data, build dashboards, and deliver insights shaping commercial decision-making across sales operations, marketing analytics, payer analytics, and real-world evidence (RWE)
Comfortable writing SQL queries and building dashboards (e.g., Tableau, Power BI, Sigma)
Skilled in presenting insights to senior leadership
Ability to balance tactical execution with strategic influence
Experience collaborating with external data providers and consultants
Ownership of analysis, synthesis, and delivery of insights
Thrives in a fast-paced environment
Flexibility in scope based on experience and interests (e.g., field effectiveness, omnichannel performance, payer dynamics, patient journey analytics)

Responsibilities

Optimize CRM systems, territory alignments, call planning, and incentive compensation (Sales Operations & Field Effectiveness)
Refine targeting and segmentation approaches to deepen HCP and account engagement
Analyze sales metrics and collaborate with Sales leadership to evaluate performance
Partner with Sales Training to ensure effective systems training for field teams
Measure and optimize marketing and digital campaign performance across HCP and patient touchpoints (Marketing & Omnichannel Analytics)
Build and maintain dashboards to track KPIs across channels
Collaborate with Marketing to define metrics, conduct test-and-learn analyses, and provide timely insights
Analyze payer coverage, formulary dynamics, and access barriers to inform pricing and contracting strategies (Market Access & Patient Analytics)
Develop dashboards tracking payer mix, pull-through, and patient affordability trends
Support Market Access and field access teams with insights that optimize payer engagement
Monitor and analyze patient access metrics (e.g., speed-to-therapy, adherence, abandonment, fulfillment) (Specialty Pharmacy & Patient Analytics)
Integrate specialty pharmacy, field, and patient services data to provide a comprehensive view of the patient journey
Analyze claims and EMR data to assess treatment patterns, adherence, and product value (Real-World Evidence (RWE) & Medical Collaboration)
Partner with Medical Affairs to support outcomes analyses, value communications, and publications
Design and deliver dashboards and reporting frameworks (Tableau, Power BI, Sigma) spanning sales, marketing, payer, and patient analytics (Cross-Functional Leadership & Analytics Enablement)
Build integrated reporting across CRM, marketing, payer, and third-party data (IQVIA, Symphony, Komodo)
Explore and apply advanced analytics techniques—including predictive modeling, machine learning, and emerging AI/LLM approaches—to uncover new insights, improve forecasting, and elevate commercial decision-making
Translate complex datasets into clear, decision-ready insights

Skills

SQL

CRM

Dashboards

Sales Operations

Marketing Analytics

Payer Analytics

Real-World Evidence

Omnichannel

Patient Journey Analytics

Territory Alignment

Corcept Therapeutics

Develops cortisol modulators for medical conditions

About Corcept Therapeutics

Corcept Therapeutics focuses on developing treatments that regulate cortisol levels in the body, which is important for managing various health issues. Their main product, Korlym, is used to treat Cushing's syndrome, a condition caused by too much cortisol. Korlym was approved by the FDA in 2012 and is the first medication specifically for this disorder. Corcept stands out from competitors by having a strong emphasis on research and development, having discovered over 1,000 unique cortisol modulators. The company aims to expand its range of treatments while also providing educational resources to healthcare professionals and patients to improve understanding and care for cortisol-related conditions.

Menlo Park, CaliforniaHeadquarters

1998Year Founded

$39.7MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Remote Work Options

Flexible Work Hours

Risks

Teva's antitrust lawsuit could lead to legal expenses and market share loss.

Heavy reliance on Korlym makes Corcept vulnerable to market fluctuations.

Recent investments may pressure Corcept for short-term financial performance, impacting R&D.

Differentiation

Corcept specializes in cortisol modulation, a niche with few direct competitors.

Korlym is the first FDA-approved treatment for Cushing's syndrome, a significant market advantage.

Corcept's extensive R&D has led to the discovery of over 1,000 selective cortisol modulators.

Upsides

Increased interest in cortisol therapies for mental health boosts Corcept's R&D prospects.

Advancements in drug delivery systems could enhance Corcept's product efficacy.

The FDA's fast-track designation supports Corcept's innovative cortisol-related treatments.

Land your dream remote job 3x faster with AI

Try Jobo Free